Promising Potential of Vaxcyte’s VAX-31 Vaccine Drives Buy Rating
at www.tipranks.com (Wed, 10-Dec 5:06 AM)
Vaxcyte (PCVX) Gets a Buy from Guggenheim
at www.tipranks.com (Tue, 9-Dec 7:25 AM)
Vaxcyte’s Strategic Phase 3 Trial Initiation and Its Market Implications
at www.tipranks.com (Mon, 8-Dec 2:35 PM)
